tiprankstipranks
Advertisement
Advertisement

ELUT Stock Latest News

Elutia Divests SimpliDerm Assets to Refocus Strategy
Company AnnouncementsElutia Divests SimpliDerm Assets to Refocus Strategy
12d ago
8K
ELUT
Elutia to sell SimpliDerm business to Cellution Biologics for $11M
PremiumThe Fly
Elutia to sell SimpliDerm business to Cellution Biologics for $11M
16d ago
ELUT
Elutia Shareholders Approve Amended Incentive Plan and Governance
PremiumCompany Announcements
Elutia Shareholders Approve Amended Incentive Plan and Governance
2M ago
8K
ELUT
Aziyo Biologics Maps Risky Path to Breast Mesh Upside
PremiumCompany Announcements
Aziyo Biologics Maps Risky Path to Breast Mesh Upside
3M ago
ELUT
Aziyo Biologics, Inc. Class A (ELUT) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Aziyo Biologics, Inc. Class A (ELUT) Q1 Earnings Cheat Sheet
3M ago
ELUT
Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win
PremiumCompany AnnouncementsElutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win
5M ago
ELUT
Elutia announces grants of inducement awards
Premium
The Fly
Elutia announces grants of inducement awards
5M ago
ELUT
Aziyo Biologics Earnings Call: Cash, Risk and 41X
Premium
Company Announcements
Aziyo Biologics Earnings Call: Cash, Risk and 41X
5M ago
ELUT
Elutia Adopts 2026 Inducement Equity Award Plan
PremiumCompany Announcements
Elutia Adopts 2026 Inducement Equity Award Plan
5M ago
8K
ELUT
Aziyo Biologics, Inc. Class A (ELUT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Aziyo Biologics, Inc. Class A (ELUT) Q4 Earnings Cheat Sheet
5M ago
ELUT
Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status
PremiumCompany Announcements
Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status
5M ago
8K
ELUT
Elutia regains compliance with Nasdaq listing requirements
PremiumThe Fly
Elutia regains compliance with Nasdaq listing requirements
5M ago
ELUT
Elutia appoints Ligotti as Chief Commercial Officer
PremiumThe FlyElutia appoints Ligotti as Chief Commercial Officer
5M ago
ELUT
Elutia reports preliminary Q4 revenue $3.3M
Premium
The Fly
Elutia reports preliminary Q4 revenue $3.3M
7M ago
ELUT
Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing
Premium
Company Announcements
Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing
7M ago
8K
ELUT
Elutia management to meet with Lake Street
PremiumThe Fly
Elutia management to meet with Lake Street
8M ago
ELUT
Aziyo Biologics Faces Nasdaq Delisting Risk Notice
PremiumCompany Announcements
Aziyo Biologics Faces Nasdaq Delisting Risk Notice
9M ago
8K
ELUT
Elutia’s Earnings Call: Strategic Moves Amid Challenges
PremiumCompany Announcements
Elutia’s Earnings Call: Strategic Moves Amid Challenges
9M ago
ELUT
Elutia Inc. Advances NXT-41x Amid Financial Developments
PremiumCompany Announcements
Elutia Inc. Advances NXT-41x Amid Financial Developments
9M ago
ELUT
Elutia reports Q3 EPS (19c) vs. (33c) last year
PremiumThe FlyElutia reports Q3 EPS (19c) vs. (33c) last year
9M ago
ELUT
Is ELUT a Buy, Before Earnings?
Premium
Pre-Earnings
Is ELUT a Buy, Before Earnings?
9M ago
ELUT
Aziyo Biologics Welcomes Guido J. Neels to Board
Premium
Company Announcements
Aziyo Biologics Welcomes Guido J. Neels to Board
10M ago
8K
ELUT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >